David M. Denton - 23 Feb 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chief Financial Officer & EVP
Signature
Susan E. Grant, by power of atty., for David M. Denton
Issuer symbol
PFE
Transactions as of
23 Feb 2023
Net transactions value
$0
Form type
4
Filing time
24 Feb 2023, 19:17:25 UTC
Previous filing
16 Nov 2022
Next filing
01 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PFE Common Stock 63,756 23 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Award $0 +103,320 $0.000000 103,320 23 Feb 2023 Common Stock 103,320 $42.30 Direct F1
transaction PFE Stock Appreciation Rights Award $0 +89,920 $0.000000 89,920 23 Feb 2023 Common Stock 89,920 $42.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F2 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.